Security key
007002108
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 9,599,852
- Total 13F shares
- 37,121,626
- Share change
- -3,027,451
- Total reported value
- $90,180,708
- Put/Call ratio
- 122%
- Price per share
- $2.43
- Number of holders
- 92
- Value change
- -$28,161,740
- Number of buys
- 44
- Number of sells
- 60
Report period
Q2 2023
Institutions
92
Top holders
10
ACET full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Adicet Bio, Inc. SEC filings
Adicet Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 007002108
Recent filing periods:
Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
78%
|
7,447,140
|
$42,895,526 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
44%
|
4,241,472
|
$24,430,879 | — | 31 Mar 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
37%
|
3,560,700
|
$20,509,632 | — | 31 Mar 2023 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
33%
|
3,143,608
|
$18,107,182 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
26%
|
2,536,802
|
$14,611,981 | — | 31 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
26%
|
2,520,000
|
$14,515,200 | — | 31 Mar 2023 | |
| Carlyle Group Inc. |
13F
|
Company |
22%
|
2,115,385
|
$12,163,464 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
18%
|
1,690,469
|
$9,737,102 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
17%
|
1,639,878
|
$9,445,698 | — | 31 Mar 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
13%
|
1,263,825
|
$7,279,632 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
13%
|
1,230,763
|
$6,525,128 | — | 31 Mar 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
8.3%
|
797,054
|
$4,591,031 | — | 31 Mar 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
7.6%
|
728,944
|
$4,198,717 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.3%
|
606,189
|
$3,491,648 | — | 31 Mar 2023 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
6%
|
580,000
|
$3,340,800 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
5.9%
|
564,457
|
$3,251,272 | — | 31 Mar 2023 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
5.8%
|
558,636
|
$3,217,743 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.8%
|
558,367
|
$3,216,362 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.2%
|
501,825
|
$2,890,512 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
315,800
|
$1,819,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.3%
|
312,977
|
$1,802,747 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.9%
|
276,763
|
$1,594,155 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.7%
|
262,432
|
$1,511,609 | — | 31 Mar 2023 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.9%
|
181,626
|
$1,046,166 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
1.8%
|
174,710
|
$1,006,328 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
170,876
|
$984,000 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.6%
|
156,833
|
$903,359 | — | 31 Mar 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
1.6%
|
154,708
|
$889,571 | — | 31 Mar 2023 | |
| Ergoteles LLC |
13F
|
Company |
1.4%
|
132,197
|
$761,455 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
112,104
|
$645,719 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
100,040
|
$576,230 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
99,306
|
$572,002 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.99%
|
94,685
|
$545,000 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.96%
|
92,296
|
$531,625 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
81,170
|
$467,539 | — | 31 Mar 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.69%
|
66,611
|
$383,680 | — | 31 Mar 2023 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.68%
|
65,729
|
$378,599 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.51%
|
49,435
|
$284,746 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.5%
|
47,618
|
$274,000 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.46%
|
44,605
|
$256,925 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.45%
|
42,910
|
$247,162 | — | 31 Mar 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.44%
|
42,331
|
$244,000 | — | 31 Mar 2023 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.44%
|
42,232
|
$243,000 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.43%
|
41,600
|
$239,616 | — | 31 Mar 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.43%
|
41,300
|
$237,888 | — | 31 Mar 2023 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.42%
|
40,329
|
$232,295 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.4%
|
38,252
|
$220,331 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.34%
|
32,960
|
$189,850 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.34%
|
32,279
|
$185,927 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.33%
|
31,414
|
$180,945 | — | 31 Mar 2023 |
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2023
As of 30 Jun 2023,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,121,626 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, TANG CAPITAL MANAGEMENT LLC, MORGAN STANLEY, BlackRock Inc., Carlyle Group Inc., VANGUARD GROUP INC, DEUTSCHE BANK AG\, and DAFNA Capital Management LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
105
Q2 2023 holders
92
Holder diff
-13
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.